VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
+33.89%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$680M
AUM Growth
+$680M
(+33%)
Cap. Flow
+$44.7M
Cap. Flow
% of AUM
6.57%
Top 10 Holdings %
Top 10 Hldgs %
79.62%
Holding
31
New
9
Increased
4
Reduced
4
Closed
6
Top Buys
| 1 |
Olema Pharmaceuticals
OLMA
|
$73.9M |
| 2 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$58.6M |
| 3 |
VistaGen Therapeutics
VTGN
|
$18.2M |
| 4 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$17M |
| 5 |
Aclaris Therapeutics
ACRS
|
$12.6M |
Top Sells
| 1 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$46.6M |
| 2 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$22.5M |
| 3 |
Cardiff Oncology
CRDF
|
$18M |
| 4 |
IMV
IMV Inc. Common Shares
IMV
|
$17.8M |
| 5 |
ALX Oncology
ALXO
|
$11.3M |
Sector Composition
| 1 | Healthcare | 86.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSDC
26
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| – | – |
-500,000
| Closed | -$5.6M |
|
|
IMV
27
DELISTED
IMV Inc. Common Shares
IMV
| – | – |
-4,000,000
| Closed | -$17.8M |
|
|
MDNA
28
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| – | – |
-92,453
| Closed | -$383K |
|
|
29
Cardiff Oncology
CRDF
$130M
| – | – |
-1,271,985
| Closed | -$18M |
|
|
30
ALX Oncology
ALXO
$54.6M
| – | – |
-300,000
| Closed | -$11.3M |
|